Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study Assessing Safety, Tolerability, Pharmacokinetics and Physiological Response (Pain Tolerance) to Single and Multiple Ascending Doses of FZ008-145 in Healthy Subjects.

NCT06685809 is registered in ClinicalTrials.gov with Guangzhou Fermion Technology Co., LTD as lead sponsor.

NCT NCT06685809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06685809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study Assessing Safety, Tolerability, Pharmacokinetics and Physiological Response (Pain Tolerance) to Single and Multiple Ascending Doses of FZ008-145 in Healthy Subjects.
Lead sponsor
Guangzhou Fermion Technology Co., LTD
Phase
Phase 1
Overall status
Completed
Start date
November 25, 2024
Completion date
April 14, 2026
Enrollment
176 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy